Small Entity Compliance Guide: Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Availability, 18849-18850 [2010-8359]

Download as PDF Federal Register / Vol. 75, No. 70 / Tuesday, April 13, 2010 / Notices Office, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, GA 30341, Telephone: (770) 488–3023, E-mail: DYB7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 5, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–8442 Filed 4–12–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0001] Food and Drug Administration/National Heart Lung and Blood Institute/ National Science Foundation Workshop on Computer Methods for Cardiovascular Devices: The Integration of Nonclinical and Clinical Models; Public Workshop AGENCY: Food and Drug Administration, HHS. sroberts on DSKD5P82C1PROD with NOTICES ACTION: Notice of public workshop. SUMMARY: The Food and Drug Administration (FDA) is announcing a public workshop entitled ‘‘FDA/NHLBI/ NSF Workshop on Computer Methods for Cardiovascular Devices: The Integration of Nonclinical and Clinical Models.’’ The workshop will include a smaller, optional session entitled ‘‘Microstructure Modeling Session.’’ FDA is cosponsoring the workshop with the National Heart Lung and Blood Institute of the National Institutes of Health and the National Science Foundation. The purpose of the workshop is to facilitate discussion between FDA and other interested parties on the use of computational modeling in the design, development, and evaluation of cardiovascular medical devices. Dates and Times: The optional session will be held on June 9, 2010, from 1 p.m. to 5:30 p.m. and the public workshop will be held on June 10 and 11, 2010, from 8 a.m. to 5 p.m. Location: The public workshop and optional session will be held at the Hilton Washington DC/Rockville Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Donna R. Lochner, Center for Devices and Radiological Health, Food and Drug Administration, VerDate Nov<24>2008 17:33 Apr 12, 2010 Jkt 220001 10903 New Hampshire Ave., Bldg. 66, rm. 1110, Silver Spring, MD 20993, 301–796–6309, donna.lochner@fda.hhs.gov. Registration: To register for the public workshop and optional session, please visit the following Web site: https:// scpd.stanford.edu/ publicViewHome.do?method=load. There is a registration fee to attend the public workshop to cover the expenses and attendees must register in advance. The fee for the meeting is $350. Students will be offered a discounted fee of $175. The exhibitors’ fee is $600 and includes registration of one person. Fees will be waived for invited speakers and the organizing committee. The registration process will be handled by the Stanford Center for Professional Development. Although the facility is spacious, registration will be on a firstcome, first-served basis. If you need special accommodations because of a disability, please contact Donna R. Lochner at least 7 days before the public workshop. SUPPLEMENTARY INFORMATION: I. Why Are We Holding This Public Workshop? The purpose of the public workshop is to facilitate discussion between FDA and other interested parties on the use of computational modeling in cardiovascular device design, development, and evaluation. II. What Are the Topics We Intend to Address at the Public Workshop? We hope to discuss a large number of issues at the public workshop, with our overall theme being the integration of computer and nonclinical models. Topics include, but are not limited to the following: • Multiscale, multiphysics, and multiphase modeling; • Modeling of cardiovascular diseases and therapies; • Patient-specific modeling, including virtual surgical planning and predictive biomedicine; • Open source projects, including public policy initiatives, database development and data presentation, and standards and protocols; and • Regulatory issues with implementation of computer modeling. III. Where Can I Find Out More About This Public Workshop? Background information on the public workshop, registration information, the agenda, information about lodging, and other relevant information will be posted, as it becomes available, on the Internet at https://www.fda.gov/ PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 18849 MedicalDevices/NewsEvents/ WorkshopsConferences/default.htm Dated: April 7, 2010. Jeffrey Shuren, Director, Center for Devices and Radiological Health. [FR Doc. 2010–8311 Filed 4–12–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–D–0183] Small Entity Compliance Guide: Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ‘‘Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation—Small Entity Compliance Guide.’’ The small entity compliance guide (SECG) is being issued for a final rule published in the Federal Register of July 9, 2009, and is intended to set forth in plain language the requirements of the regulation and to help small businesses understand the regulation. Elsewhere in this issue of the Federal Register, FDA is amending its July 9, 2009, regulation to correct the date by which producers must register their farm with FDA, reflect a change in the address and telephone number for requesting copies of Form No. 3733, and reflect a change in the address to which producers must send their CD–ROM. DATES: Submit electronic or written comments on the SECG at any time. ADDRESSES: Submit electronic comments on the SECG to https:// www.regulations.gov. Submit written comments on the SECG to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit written requests for single copies of the SECG to the Division of Plant and Dairy Food Safety/ Office of Food Safety, Center for Food Safety and Applied Nutrition (HFS– 315), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, or fax your request to 301– 436–1070. Send two self-addressed adhesive labels to assist that office in processing your request. See the E:\FR\FM\13APN1.SGM 13APN1 18850 Federal Register / Vol. 75, No. 70 / Tuesday, April 13, 2010 / Notices section for electronic access to the SECG. FOR FURTHER INFORMATION CONTACT: Nancy S. Bufano, Center for Food Safety and Applied Nutrition (HFS–315), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–1493. SUPPLEMENTARY INFORMATION: SUPPLEMENTARY INFORMATION I. Background In the Federal Register of July 9, 2009 (74 FR 33030), FDA issued a final rule requiring shell egg producers to implement measures to prevent Salmonella Enteritidis (SE) from contaminating eggs on the farm and from further growth during storage and transportation, and requiring these producers to maintain records concerning their compliance with the rule and to register with FDA. The final rule became effective September 8, 2009. FDA examined the economic implications of the final rule as required by the Regulatory Flexibility Act (5 U.S.C. 601–612) and determined that the final rule will have a significant economic impact on a substantial number of small entities. In compliance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104–121), FDA is making available this SECG stating in plain language the requirements of the regulation. FDA is issuing this SECG as level 2 guidance consistent with FDA’s good guidance practices regulation (21 CFR 10.115(c)(2)). The SECG represents FDA’s current thinking on the prevention of SE in shell eggs. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. modify, or disapprove the information collection provisions in this final rule. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. III. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) electronic or written comments regarding this SECG. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The SECG and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. IV. Electronic Access Persons with access to the Internet may obtain the document at https:// www.fda.gov/FoodGuidances or https:// www.regulations.gov. Dated: April 7, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–8359 Filed 4–12–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2009–0026] National Protection and Programs Directorate; Chemical Facility AntiTerrorism Standards Personnel Surety Program sroberts on DSKD5P82C1PROD with NOTICES II. Paperwork Reduction Act of 1995 AGENCY: National Protection and Programs Directorate, DHS. ACTION: 30-day notice and request for comments: New information collection request 1670–NEW. This SECG refers to collections of information described in FDA’s final rule that published in the Federal Register of July 9, 2009 (74 FR 33030 at 33089), and that became effective on September 8, 2009. As stated in the final rule, these collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA) (44 U.S.C. 3501–3520). In compliance with the PRA (44 U.S.C. 3507(d)), the agency has submitted the information collection provisions of the final rule to OMB for review. FDA will publish a notice in the Federal Register announcing OMB’s decision to approve, The Department of Homeland Security (DHS), National Protection and Programs Directorate (NPPD), Office of Infrastructure Protection (IP), Infrastructure Security Compliance Division (ISCD) will be submitting the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is a new information collection. A 60-day public notice for comments was previously published in the Federal Register on June 10, 2009, at 74 FR 27555. Comments were received and responses VerDate Nov<24>2008 17:33 Apr 12, 2010 Jkt 220001 SUMMARY: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 are in this notice. The purpose of this notice is to solicit additional comments during a 30-day public comment period prior to the submission of this collection to OMB. The submission describes the nature of the information collection, the categories of respondents, the estimated burden, and cost. DATES: Comments are encouraged and will be accepted until May 13, 2010. This process is conducted in accordance with 5 CFR 1320.8. ADDRESSES: Interested persons are invited to submit comments on the proposed information collection through the Federal Rulemaking Portal at https://www.regulations.gov. Follow the instructions for submitting comments. Comments must be identified by docket number DHS– 2009–0026. Comments that include trade secrets, confidential commercial or financial information, Chemical-terrorism Vulnerability Information (CVI), Sensitive Security Information (SSI), or Protected Critical Infrastructure Information (PCII) should not be submitted to the public regulatory docket. Please submit such comments separately from other comments in response to this notice. Comments containing trade secrets, confidential commercial or financial information, CVI, SSI, or PCII should be appropriately marked and submitted by mail to the DHS/NPPD/IP/ISCD CFATS Program Manager at the Department of Homeland Security, 245 Murray Lane, SW., Mail Stop 0610, Arlington, VA 20528–0610. Comments must be identified by docket number DHS– 2009–0026. FOR FURTHER INFORMATION CONTACT: A copy of this ICR, with applicable supporting documentation, may be obtained through the Federal Rulemaking Portal at https:// www.regulations.gov. SUPPLEMENTARY INFORMATION: Program Description The Chemical Facility Anti-Terrorism Standards (CFATS), 6 CFR part 27, require high-risk chemical facilities to submit information about facility personnel and, as appropriate, unescorted visitors with access to restricted areas or critical assets at those facilities. This information will be vetted by the Federal Government against the Terrorist Screening Database (TSDB), the consolidated and integrated terrorist watchlist maintained by the Federal Government, to identify known or suspected terrorists (i.e., individuals with terrorist ties). E:\FR\FM\13APN1.SGM 13APN1

Agencies

[Federal Register Volume 75, Number 70 (Tuesday, April 13, 2010)]
[Notices]
[Pages 18849-18850]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8359]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-D-0183]


Small Entity Compliance Guide: Prevention of Salmonella 
Enteritidis in Shell Eggs During Production, Storage, and 
Transportation; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
availability of a guidance entitled ``Prevention of Salmonella 
Enteritidis in Shell Eggs During Production, Storage, and 
Transportation--Small Entity Compliance Guide.'' The small entity 
compliance guide (SECG) is being issued for a final rule published in 
the Federal Register of July 9, 2009, and is intended to set forth in 
plain language the requirements of the regulation and to help small 
businesses understand the regulation. Elsewhere in this issue of the 
Federal Register, FDA is amending its July 9, 2009, regulation to 
correct the date by which producers must register their farm with FDA, 
reflect a change in the address and telephone number for requesting 
copies of Form No. 3733, and reflect a change in the address to which 
producers must send their CD-ROM.

DATES: Submit electronic or written comments on the SECG at any time.

ADDRESSES:  Submit electronic comments on the SECG to https://www.regulations.gov. Submit written comments on the SECG to the 
Division of Dockets Management (HFA-305), Food and Drug Administration, 
5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit written 
requests for single copies of the SECG to the Division of Plant and 
Dairy Food Safety/Office of Food Safety, Center for Food Safety and 
Applied Nutrition (HFS-315), Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, or fax your request to 301-436-
1070. Send two self-addressed adhesive labels to assist that office in 
processing your request. See the

[[Page 18850]]

SUPPLEMENTARY INFORMATION section for electronic access to the SECG.

FOR FURTHER INFORMATION CONTACT: Nancy S. Bufano, Center for Food 
Safety and Applied Nutrition (HFS-315), Food and Drug Administration, 
5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-1493.

SUPPLEMENTARY INFORMATION:

I. Background

     In the Federal Register of July 9, 2009 (74 FR 33030), FDA issued 
a final rule requiring shell egg producers to implement measures to 
prevent Salmonella Enteritidis (SE) from contaminating eggs on the farm 
and from further growth during storage and transportation, and 
requiring these producers to maintain records concerning their 
compliance with the rule and to register with FDA. The final rule 
became effective September 8, 2009.
    FDA examined the economic implications of the final rule as 
required by the Regulatory Flexibility Act (5 U.S.C. 601-612) and 
determined that the final rule will have a significant economic impact 
on a substantial number of small entities. In compliance with section 
212 of the Small Business Regulatory Enforcement Fairness Act (Public 
Law 104-121), FDA is making available this SECG stating in plain 
language the requirements of the regulation.
    FDA is issuing this SECG as level 2 guidance consistent with FDA's 
good guidance practices regulation (21 CFR 10.115(c)(2)). The SECG 
represents FDA's current thinking on the prevention of SE in shell 
eggs. It does not create or confer any rights for or on any person and 
does not operate to bind FDA or the public. An alternative approach may 
be used if such approach satisfies the requirements of the applicable 
statutes and regulations.

II. Paperwork Reduction Act of 1995

    This SECG refers to collections of information described in FDA's 
final rule that published in the Federal Register of July 9, 2009 (74 
FR 33030 at 33089), and that became effective on September 8, 2009. As 
stated in the final rule, these collections of information are subject 
to review by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995 (the PRA) (44 U.S.C. 3501-3520). In 
compliance with the PRA (44 U.S.C. 3507(d)), the agency has submitted 
the information collection provisions of the final rule to OMB for 
review. FDA will publish a notice in the Federal Register announcing 
OMB's decision to approve, modify, or disapprove the information 
collection provisions in this final rule. An agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

III. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) electronic or written comments regarding this SECG. 
Submit a single copy of electronic comments or two paper copies of any 
mailed comments, except that individuals may submit one paper copy. 
Comments are to be identified with the docket number found in brackets 
in the heading of this document. The SECG and received comments may be 
seen in the Division of Dockets Management between 9 a.m. and 4 p.m., 
Monday through Friday.

IV. Electronic Access

    Persons with access to the Internet may obtain the document at 
https://www.fda.gov/FoodGuidances or https://www.regulations.gov.

    Dated: April 7, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-8359 Filed 4-12-10; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.